86 related articles for article (PubMed ID: 27107064)
1. Dual Roles of 17-β Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma.
Chen KC; Lin CM; Huang CJ; Chen SK; Wu ST; Chiang HS; Ku WC
Cancer Genomics Proteomics; 2016; 13(3):219-30. PubMed ID: 27107064
[TBL] [Abstract][Full Text] [Related]
2. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
[TBL] [Abstract][Full Text] [Related]
5. Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1.
Liu Y; Xu Y; Li X; Chen Z
Mol Med Rep; 2015 Apr; 11(4):2717-22. PubMed ID: 25482028
[TBL] [Abstract][Full Text] [Related]
6. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
[TBL] [Abstract][Full Text] [Related]
7. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
8. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
[TBL] [Abstract][Full Text] [Related]
9. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
Rosendahl AH; Forsberg G
Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis.
Kim H; Tarhuni A; Abd Elmageed ZY; Boulares AH
J Transl Med; 2015 Jul; 13():233. PubMed ID: 26183824
[TBL] [Abstract][Full Text] [Related]
11. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
Chang I; Liu J; Majid S; Saini S; Zaman MS; Yamamura S; Shahryari V; Chiyomaru T; Deng G; Dahiya R; Tanaka Y
Carcinogenesis; 2012 Feb; 33(2):420-6. PubMed ID: 22159223
[TBL] [Abstract][Full Text] [Related]
13. Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.
Rajandram R; Bennett NC; Wang Z; Perry-Keene J; Vesey DA; Johnson DW; Gobe GC
Pathology; 2012 Aug; 44(5):453-9. PubMed ID: 22810054
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
15. Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.
Chen D; Li Y; Su Z; Yu Z; Yu W; Li Y; Gui Y; Yang S; Lai Y
Mol Med Rep; 2015 Feb; 11(2):1278-83. PubMed ID: 25370896
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
Morais C; Pat B; Gobe G; Johnson DW; Healy H
Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
[TBL] [Abstract][Full Text] [Related]
17. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
19. KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro.
Hu J; Zhang LC; Song X; Lu JR; Jin Z
Int J Clin Exp Pathol; 2015; 8(8):9182-8. PubMed ID: 26464664
[TBL] [Abstract][Full Text] [Related]
20. Significant induction of apoptosis in renal cell carcinoma cells transfected with cationic multilamellar liposomes containing the human interferon-β gene through activation of the intracellular type 1 interferon signal pathway.
Takaha N; Nakanishi H; Kimura Y; Hongo F; Kamoi K; Kawauchi A; Mizuno M; Yoshida J; Wakabayashi T; Miki T
Int J Oncol; 2012 May; 40(5):1441-6. PubMed ID: 22344395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
